With so many health care providers, thought leaders, journalists, and policymakers active on Twitter, it's easy to miss tweets that are informative, provocative, or entertaining. Here are 10 health care tweets that caught our eyes this week (in no particular order).
1) Dan O'Neill, health care policy fellow at the National Academy of Medicine, shares his thoughts on why value-based care has become popular.
— Dan O'Neill (@dp_oneill) October 8, 2019
2) Aaron Carroll, a professor of pediatrics at Indiana University School of Medicine, shares his thoughts on a controversial study that suggested the evidence that red meat is bad for your health may not be as strong as previously thought.
— Aaron E. Carroll (@aaronecarroll) October 4, 2019
3) Karan Chhabra, a researcher at the National Clinician Scholars Program at the University of Michigan Institute for Healthcare Policy & Innovation, shares a Politico infographic on surprise billing legislation.
— Karan Chhabra, MD (@krchhabra) October 9, 2019
4) Ashish Jha, director of the Harvard Global Health Institute, shares a paper that argues that a quarter of health spending is wasteful.
— Ashish K. Jha (@ashishkjha) October 8, 2019
5) Sam Baker, health care editor for Axios, shares an article about price hikes of brand name drugs.
— Sam Baker (@sam_baker) October 8, 2019
6) Emily Farris, a political scientist, makes a joke about problems with accurate data.
— Emily M. Farris (@emayfarris) October 3, 2019
7) Larry Levitt, EVP for health policy at the Kaiser Family Foundation, shares the comments he has received on President Trump's executive orders on Medicare and immigration.
— Larry Levitt (@larry_levitt) October 6, 2019
8) Satirical publication The Onion shares an article satirizing CDC's preparations for flu season.
— The Onion (@TheOnion) October 3, 2019
9) Health Care Innovation Group shares an article describing how behavioral psychology and design thinking can help change patient behavior.
— Healthcare Innovation (@HCInnovationGrp) October 9, 2019
10) Vinay Prasad, associate professor of medicine at Oregon Health and Science University, shares a thread narrating his thoughts on FDA's use of surrogate drugs.
— Vinay Prasad 2.0 (@VPrasadMDMPH) October 8, 2019